Nobel mini-symposium at KI on advances in antibody diversification and engineering
Leading international researchers in immunology, antibody biology, and therapeutic engineering will gather at the Nobel Forum at Karolinska Institutet on 4-5 June 2026, for Nobel mini-symposium No. 63, "Advances in Antibody Diversification and Engineering: Mechanisms, Technologies, and Therapeutic Potential".
The symposium will highlight recent advances in the mechanisms of antibody diversification, immune regulation, autoimmunity, and therapeutic antibody development. Scientific sessions will cover somatic hypermutation, Fc receptor biology, antibody-mediated disease, and emerging computational approaches for antibody and protein engineering.
The programme will feature keynote lectures, invited talks, short talks, poster presentations, and a special virtual lecture by Nobel Laureate David Baker on computational strategies transforming antibody therapeutics. The symposium will bring together internationally recognized experts from Europe, North America, and Asia working at the forefront of immunology, infectious disease research, structural biology, and AI-driven protein design.
The meeting is organised by Qiang Pan-Hammarström and Mikael Karlsson at Karolinska Institutet, together with Michela Di Virgilio from the Max Delbrück Center, Germany.
Advance registration is required. Due to limited capacity at the Nobel Forum, participation is limited and only confirmed registered participants will be able to attend.